KOSDAQ - Delayed Quote KRW
HLB bioStep Co.,Ltd. (278650.KQ)
1,620.00
+14.00
+(0.87%)
At close: 2:45:12 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
58,168,784.88
58,168,784.88
52,814,062.37
86,277,023.44
64,403,026.84
Cost of Revenue
16,844,913
16,844,913
17,046,244
31,607,034
22,347,444
Gross Profit
41,323,871.88
41,323,871.88
35,767,818.37
54,669,989.44
42,055,582.84
Operating Expense
54,289,319
54,289,319
36,954,019
48,224,035
31,804,824
Operating Income
-12,965,447.12
-12,965,447.12
-1,186,200.63
6,445,954.44
10,250,758.84
Net Non Operating Interest Income Expense
948,941.48
948,941.48
-1,986,654.31
-2,837,654.22
224,808.83
Pretax Income
-11,527,644.70
-11,527,644.70
325,663.90
-2,344,601.06
12,826,511.34
Tax Provision
-1,835,013.88
-1,835,013.88
379,902.59
-1,461,869.22
1,294,557.29
Net Income Common Stockholders
-8,564,408.97
-8,564,408.97
-164,044.13
-1,008,003.64
11,030,553.79
Basic EPS
-100.00
--
-2.00
-14.00
18.00
Diluted EPS
-100.00
--
-2.00
-14.00
17.56
Basic Average Shares
85,644.09
--
82,022.07
72,000.26
68,144.63
Diluted Average Shares
85,644.09
--
82,022.07
72,000.26
69,987.44
Total Operating Income as Reported
-12,965,447.08
-12,965,447.08
-1,276,200.67
6,414,119.68
9,822,841.17
Rent Expense Supplemental
3,100
3,100
2,700
57,597
42,519
Total Expenses
71,134,232
71,134,232
54,000,263
79,831,069
54,152,268
Net Income from Continuing & Discontinued Operation
-8,564,408.97
-8,564,408.97
-164,044.13
-1,008,003.64
11,030,553.79
Normalized Income
-8,555,562.74
-8,555,562.74
-2,748,740.29
2,379,858.29
12,579,401.78
Interest Income
1,821,376
1,821,376
1,468,911
1,401,445
84,996
Interest Expense
858,958
858,958
3,470,889
4,246,318
184,701
Net Interest Income
948,941.48
948,941.48
-1,986,654.31
-2,837,654.22
224,808.83
EBIT
-10,668,686.70
-10,668,686.70
3,796,552.90
1,901,716.94
13,011,212.34
EBITDA
-5,966,093.70
-5,966,093.70
7,272,295.90
6,004,861.94
16,037,529.34
Reconciled Cost of Revenue
16,844,913
16,844,913
17,046,244
31,607,034
22,347,444
Reconciled Depreciation
4,702,593
4,702,593
3,475,743
4,103,145
3,026,317
Net Income from Continuing Operation Net Minority Interest
-8,564,408.97
-8,564,408.97
-164,044.13
-1,008,003.64
11,030,553.79
Total Unusual Items Excluding Goodwill
-10,521
-10,521
3,400,916
-4,672,913
-1,722,719
Total Unusual Items
-10,521
-10,521
3,400,916
-4,672,913
-1,722,719
Normalized EBITDA
-5,955,572.70
-5,955,572.70
3,871,379.90
10,677,774.94
17,760,248.34
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,674.77
-1,674.77
816,219.84
-1,285,051.08
-173,871.01
12/31/2021 - 11/27/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade